Verrica Data Show YCANTH Response Across Disease Duration
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) will present new Phase 3 analyses showing its FDA-approved YCANTH treatment produced higher molluscum contagiosum clearance rates than vehicle regardless of …
Verrica Data Show YCANTH Response Across Disease Duration Read More